SUBSCRIBE
SUBSCRIBE
News   Business

AVANIR Pharmaceuticals Announces Fiscal 2009 Fourth Quarter and Full Year Financial Results

November 24, 2009 | 
1 min read
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals, Inc. (NASDAQ:AVNR) today reported unaudited financial results for the three and twelve months ended September 30, 2009.
Earnings
MORE ON THIS TOPIC
Table tennis balls in contrast. Diversity, difference, opposition, exclusion or confrontation concept.
Earnings
BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout
April 30, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
CAR T therapy developer Autolus laying off 13% of workforce
April 30, 2026
 · 
47 min read
 · 
BioSpace Editorial Staff
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Avalyn beats expectations with $300M debut
April 30, 2026
 · 
11 min read
 · 
Editorial Team
Cost cutting, budget slashing, financial control. Trendy halftone collage. Concept of cost cutting, expense management, and business strategy. Vector illustration
Earnings
Lilly clocks 56% revenue increase in Q1 but declining prices stunt growth
April 30, 2026
 · 
2 min read
 · 
Annalee Armstrong